| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.57 | 0.04 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.39 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.2 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.28 | 0.05 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.25 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.23 | 0.05 |